Literature DB >> 4814997

Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane.

A J Salsbury, K Burrage, K Hellmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4814997

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  20 in total

Review 1.  [Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].

Authors:  W Rhomberg; M Grass
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

2.  Antimetastatic drugs: laboratory to clinic.

Authors:  K Hellmann
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

3.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Authors:  J M Gilbert; K Hellmann; M Evans; P G Cassell; B Stoodley; H Ellis; C Wastell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma.

Authors:  V Grill; F Mallardi; S Zorzet; L Perissin; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

6.  Antimetastatic effects of razoxane in a rat osteosarcoma model.

Authors:  F Wingen; H Spring; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

7.  New invasion assay using endothelial cells grown on native human basement membrane.

Authors:  R G Russo; C M Foltz; L A Liotta
Journal:  Clin Exp Metastasis       Date:  1983 Apr-Jun       Impact factor: 5.150

8.  Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192.

Authors:  Z X Huang; P M May; K M Quinlan; D R Williams; A M Creighton
Journal:  Agents Actions       Date:  1982-10

9.  Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.

Authors:  Walter Rhomberg; Helmut Eiter; Franz Schmid; Christoph H Saely
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

10.  Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane.

Authors:  S L Maloney; D C Sullivan; S Suchting; J M J Herbert; E M Rabai; Z Nagy; J Barker; S Sundar; R Bicknell
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.